Part 4 Β· Chapter 4.3

Smooth Muscle

Smooth muscle is non-striated, involuntarily controlled, and operates under fundamentally different regulation from striated muscle: contraction is activated via myosin-light-chain kinase (MLCK) phosphorylation rather than troponin-C Ca2+ binding. This chapter covers MLCK/MLCP dynamics, Ca2+sensitisation via Rho kinase, and visceral smooth-muscle function.

1. MLCK Pathway

Cytosolic Ca2+ binds calmodulin (CaM); Ca2+4-CaM activates myosin-light-chain kinase (MLCK); MLCK phosphorylates Ser19 of the regulatory myosin light chain (MLC); phosphorylated myosin cycles cross-bridges on actin:

\[ \text{Ca}^{2+} \to \text{CaM} \to \text{MLCK} \to \text{pMLC}_{\text{Ser19}} \to \text{contraction} \]

Myosin-light-chain phosphatase (MLCP) dephosphorylates pMLC and relaxes the muscle. The force is set by the MLCK/MLCP ratio, not by Ca2+ alone.

2. Ca2+ Sensitisation

Rho kinase (ROCK) phosphorylates MYPT1 (MLCP regulatory subunit), inhibiting MLCP. This shifts the MLCK/MLCP balance toward phosphorylation, producing force at lower Ca2+ β€” so-called Ca2+ sensitisation. Gq (via RhoGEF) and G12/13 activate Rho. Fasudil and Y-27632 are Rho-kinase inhibitors; sildenafil indirectly opposes this via cGMP.

Simulation: Ca-MLCK-Force Coupling

Python
script.py33 lines

Click Run to execute the Python code

Code will be executed with Python 3 on the server

3. Contractile Apparatus

Smooth-muscle thin filaments anchor to cytoplasmic dense bodies (Ξ±-actinin) and membrane dense plaques rather than Z-discs. Myosin II filaments are shorter and irregularly-oriented. The absence of striation reflects this lack of sarcomeric organisation. The consequence: slower but more economic contraction, ~1% of skeletal ATP consumption for the same tension, and a much wider operating length range.

4. Phasic vs Tonic Smooth Muscle

Phasic smooth muscle (GI, ureter, oviduct) produces rhythmic contractions coordinated by slow-wave-generating interstitial cells of Cajal (ICC). Tonic smooth muscle (vascular, airway) maintains sustained tone. Asthma, hypertension, and IBS all reflect smooth-muscle dysregulation; therapeutic targets include Ξ²2 agonists (albuterol, salbutamol), L-type Ca2+channel blockers (amlodipine, nifedipine), and guanylyl-cyclase stimulators.

Key References

β€’ Somlyo, A. P. & Somlyo, A. V. (2003). β€œCa2+ sensitivity of smooth muscle and nonmuscle myosin II.” Physiol. Rev., 83, 1325–1358.

β€’ Webb, R. C. (2003). β€œSmooth muscle contraction and relaxation.” Adv. Physiol. Educ., 27, 201–206.

β€’ Hirano, K. (2007). β€œCurrent topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle.” J. Pharmacol. Sci., 104, 109–115.

Rate this chapter: